Nifty500 Equal Weight PB	3.8
Nifty500 Equal Weight PE	29.0
Nifty500 Equal Weight DIV	0.9
Nifty500 Equal Weight EPS	497.7

Nifty500 Equal Weight News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Nifty500 Equal Weight from all sources in a single place.

Sobha Ltd.

19 Oct 2025, 03:28PM

1525.80

-1.34%

Sobha to launch 22K cr worth housing projects over 18 months

Business Line

Company reported 61% growth in its sales booking to 1,902.6 crore in the second quarter of this fiscal.

Sobha Ltd. average weekly volume is high.

RBL Bank Ltd.

19 Oct 2025, 03:24PM

299.50

-2.36%

Emirates NBD Investment In RBL Bank Will Trigger Open Offer: CEO

NDTV Profit

The open offer will take place after all regulatory approvals. Preferential placement will be followed 15 days post open offer.

RBL Bank Ltd. is trading above all available SMAs

RBL Bank eyes wealth management after Emirates NBD acquires 60% stake

Business Standard | 19 Oct 2025, 02:39PM 5 more

Indian Overseas Bank

19 Oct 2025, 02:10PM

38.83

-2.36%

Company Update

Indian Overseas Bank - 532388 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of notice of Extraordinary General Meeting scheduled on 20.11.2025

pdf

Reliance Industries Ltd.

19 Oct 2025, 01:46PM

1416.80

1.32%

Reliance to commence solar power generation from Kutch project in H1 FY27

Business Standard

Reliance Industries will commence solar power generation in the first half of the next financial year from its mega renewable energy project in Kutch, Gujarat, a site spread over an area nearly three times the size of Singapore. The project is part of the oil-to-telecom conglomerate's broader push towards clean energy and achieving net-zero carbon emissions by 2035. In an investor presentation post announcement of its second quarter earnings, Reliance said project development across the 5,50,000-acre site in Kutch is progressing well, with engineering and feasibility studies completed, and the site is currently in various stages of land development. "Expected to start commissioning solar generation during the first half of the next year for captive requirements plus green fuels production," it said. Four years ago, Reliance Chairman and Managing Director Mukesh Ambani announced a USD 10 billion investment in a 'new energy' business. That was seen as a notable change of tide, given

Reliance Industries .. has an average target of 1607.67 from 3 brokers.

Bharti Airtel Ltd.

19 Oct 2025, 01:09PM

2012.00

2.27%

Mcap of 7 top valued firms jumps by 2.16 trn, RIL, Airtel biggest gainers

Business Standard

The combined market valuation of seven of the top-10 most valued firms surged by Rs 2,16,544.29 crore last week, with Reliance Industries and Bharti Airtel stealing the limelight, in tandem with an optimistic trend in equities. Last week, the BSE benchmark jumped 1,451.37 points or 1.75 per cent. From the top-10 pack, Reliance Industries, HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, Bajaj Finance and Hindustan Unilever were the gainers, while Tata Consultancy Services (TCS), Infosys and Life Insurance Corporation of India (LIC) faced erosion from their valuation. The market valuation of Reliance Industries jumped Rs 47,363.65 crore to Rs 19,17,483.71 crore, the most among the top-10 firms. Bharti Airtel added Rs 41,254.73 crore taking its valuation to Rs 11,47,235.08 crore. The market capitalisation (mcap) of ICICI Bank surged by Rs 40,123.88 crore to Rs 10,26,491.35 crore and that of HDFC Bank rallied Rs 33,185.59 crore to Rs 15,40,210.78 crore. The valuation of Ba

FundsIndia released a Buy report for Bharti Airtel Ltd. with a price target of 2252.0 on 03 Oct, 2025.

Dr. Reddy's Laboratories Ltd.

19 Oct 2025, 12:51PM

1255.90

1.27%

Glenmark, Dr Reddy's recall products in US over manufacturing issues: USFDA

Business Standard

Drugmakers Glenmark and Dr Reddy's Laboratories are recalling products in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per its latest Enforcement Report, the US health regulator noted that a US-based unit of Glenmark Pharmaceuticals is recalling 26,928 packs of oral contraceptive medication in the US. Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc, USA is recalling the affected lot of Viorele, Desogestrel and Ethinyl Estradiol (USP, 0.15 mg/ 0.02 mg) and Ethinyl Estradiol tablets due to "failed impurities/degradation specifications." The affected lot was produced at Mumbai-headquartered drug maker's Goa manufacturing facility. The drug firm issued the Class II nationwide recall on September 3, 2025. USFDA stated that a US-based subsidiary of Dr Reddy's Laboratories is recalling the medication used to provide muscle relaxation during surgery. Princeton, New Jersey-based Dr. Reddy's Laboratories, Inc is recalling 571 vials o

Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.

HDFC Bank Ltd.

19 Oct 2025, 12:43PM

1002.55

0.82%

HDFC Bank doesn't see AI leading to layoffs: CEO

Business Line

AI is not going to result in any layoff whatsoever in our bank, at least; Because I see this as a massive opportunity to move people from the backend to the front end or to the technology end

Number of MF schemes increased from 698 to 726 in Sep 2025 qtr.

No layoffs expected from AI, says HDFC Bank's CEO amid tech shift

Business Standard | 19 Oct 2025, 12:42PM 7 more

Eternal Ltd.

19 Oct 2025, 12:40PM

342.65

-1.49%

Company Update

Eternal Ltd - 543320 - General Updates

BSE India

Eternal Limited has informed the exchange regarding the order received from Deputy Commissioner, State Tax, Lucknow, Uttar Pradesh

pdf

IDFC First Bank Ltd.

19 Oct 2025, 12:26PM

71.88

0.13%

Earnings Call

IDFC First Bank Ltd - 539437 - Audio Recording Of Earnings Call (Q2-FY26)

BSE India

Link of Audio Recording of Earnings Call for Q2-FY26

pdf

AstraZeneca Pharma India Ltd.

19 Oct 2025, 12:09PM

9178.50

0.85%

AstraZeneca's Datroway extends survival in aggressive breast cancer

Business Line

Patients with triple-negative breast cancer who were given the drug, Datroway, had a median overall survival of 23.7 months, compared with 18.7 months for those given just chemotherapy

Number of FII/FPI investors increased from 164 to 181 in Jun 2025 qtr.